54 related articles for article (PubMed ID: 38608913)
21. Manipulation of JAK/STAT Signalling by High-Risk HPVs: Potential Therapeutic Targets for HPV-Associated Malignancies.
Morgan EL; Macdonald A
Viruses; 2020 Sep; 12(9):. PubMed ID: 32899142
[TBL] [Abstract][Full Text] [Related]
22. Oncogenic Human Papillomavirus: Application of CRISPR/Cas9 Therapeutic Strategies for Cervical Cancer.
Zhen S; Li X
Cell Physiol Biochem; 2017; 44(6):2455-2466. PubMed ID: 29268281
[TBL] [Abstract][Full Text] [Related]
23. The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications.
Hu Z; Ma D
Cancer Med; 2018 Oct; 7(10):5217-5236. PubMed ID: 30589505
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis and management of oncogenic cervical human papillomavirus infection.
Gravitt PE; Jamshidi R
Infect Dis Clin North Am; 2005 Jun; 19(2):439-58. PubMed ID: 15963882
[TBL] [Abstract][Full Text] [Related]
25. Cervical cancer vaccines: recent advances in HPV research.
Eiben GL; da Silva DM; Fausch SC; Le Poole IC; Nishimura MI; Kast WM
Viral Immunol; 2003; 16(2):111-21. PubMed ID: 12828864
[TBL] [Abstract][Full Text] [Related]
26. [Human papillomavirus and cervical cancer].
Matsumoto K
Nihon Rinsho; 2007 Nov; 65(11):2113-24. PubMed ID: 18018579
[TBL] [Abstract][Full Text] [Related]
27. The potential utility of HPV genotyping in screening and clinical management.
Castle PE
J Natl Compr Canc Netw; 2008 Jan; 6(1):83-95. PubMed ID: 18267061
[TBL] [Abstract][Full Text] [Related]
28. Biology and pathological associations of the human papillomaviruses: a review.
Cheah PL; Looi LM
Malays J Pathol; 1998 Jun; 20(1):1-10. PubMed ID: 10879257
[TBL] [Abstract][Full Text] [Related]
29. [Epidemiology of cervical papillomavirus infections. Recent knowledge].
Mougin C; Dalstein V; Prétet JL; Gay C; Schaal JP; Riethmuller D
Presse Med; 2001 Jun; 30(20):1017-23. PubMed ID: 11433694
[TBL] [Abstract][Full Text] [Related]
30. [HPV infection of the genital system: new findings].
Hrgović Z; Salihagić A; Kusan M
Lijec Vjesn; 1999 Jun; 121(6):198-203. PubMed ID: 10494156
[TBL] [Abstract][Full Text] [Related]
31. DNA damage response is hijacked by human papillomaviruses to complete their life cycle.
Hong SY
J Zhejiang Univ Sci B; 2017 Mar; 18(3):215-232. PubMed ID: 28271657
[TBL] [Abstract][Full Text] [Related]
32. [HPV: Carcinogenic implications and preventive measures].
Bernichon E; Espenel S; Méry B; Trone JC; Rehalia-Blanchard A; He YM; Rancoule C; Magné N
Presse Med; 2019; 48(7-8 Pt 1):756-766. PubMed ID: 31307878
[TBL] [Abstract][Full Text] [Related]
33. Susceptibility to cervical cancer: an overview.
de Freitas AC; Gurgel AP; Chagas BS; Coimbra EC; do Amaral CM
Gynecol Oncol; 2012 Aug; 126(2):304-11. PubMed ID: 22484226
[TBL] [Abstract][Full Text] [Related]
34. Pitfalls in the epidemiologic classification of human papillomavirus types associated with cervical cancer using polymerase chain reaction: driver and passenger.
Matsukura T; Sugase M
Int J Gynecol Cancer; 2008; 18(5):1042-50. PubMed ID: 18248389
[TBL] [Abstract][Full Text] [Related]
35. Molecular pathogenesis of cervical cancer.
Ibeanu OA
Cancer Biol Ther; 2011 Feb; 11(3):295-306. PubMed ID: 21239888
[TBL] [Abstract][Full Text] [Related]
36. Nanotechnology in the management of cervical cancer.
Chen J; Gu W; Yang L; Chen C; Shao R; Xu K; Xu ZP
Rev Med Virol; 2015 Mar; 25 Suppl 1():72-83. PubMed ID: 25752817
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus DNA methylation as a potential biomarker for cervical cancer.
Clarke MA; Wentzensen N; Mirabello L; Ghosh A; Wacholder S; Harari A; Lorincz A; Schiffman M; Burk RD
Cancer Epidemiol Biomarkers Prev; 2012 Dec; 21(12):2125-37. PubMed ID: 23035178
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic HPV vaccines.
Hancock G; Hellner K; Dorrell L
Best Pract Res Clin Obstet Gynaecol; 2018 Feb; 47():59-72. PubMed ID: 29108943
[TBL] [Abstract][Full Text] [Related]
39. Papillomaviruses and cancer: commonalities and differences in HPV carcinogenesis at different sites of the body.
Egawa N
Int J Clin Oncol; 2023 Aug; 28(8):956-964. PubMed ID: 37199886
[TBL] [Abstract][Full Text] [Related]
40. Immunopathogenesis of HPV-Associated Cancers and Prospects for Immunotherapy.
Smola S
Viruses; 2017 Sep; 9(9):. PubMed ID: 28895886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
